RE:RE:RE:RE:RE:Possible SONA competition?I think its a coin toss at this time. Their data is either going to be good or not. The MRI data sounds OK at this point, but it still doesn't have enough description to mean anything to me. And efforts to get a better description have been unanswered. So lets see what they come up with for their FDA EUA submission. If their field trial data is good, their product will sell well, especially given the new focus on POC testing in the USA.
The thing that doesn't add up to me is this: Any company can sell a product as "Research Use Only"... They don't need any certicfication or approval to do so. So why arent they selling as a Research use only product? This could help: generate some revenue on their books, start to get some market acceptance, and REALLY critically see some results from their product.
I'm optimistic, but cautious.